HubSpot Halved to ~17x Forward Earnings. Whether That's Cheap Comes Down to One Number

HubSpot has been cut about in half over the past year and is down roughly 44% year to date. That alone is not remarkable — plenty of software names have been through a de-rating. What's unusual is what the halved stock left behind: a company that grew revenue 20% in its most recent quarter, with a near-18% free cash flow margin. A 20%-grower at these prices is either the market seeing something the numbers don't yet, or a doomsday being priced in that the fundamentals don't support. Deciding which is the entire investment question here.

A beat that cut the stock a fifth

Start with the quarter that broke it. HubSpot, the front-office software platform that dominates the small-and-mid-market CRM category, reported its June 2026 quarter on August 5 and beat on both lines. Revenue of $911.7 million was up 19.8% against roughly a $898 million expectation, and adjusted earnings of $3.26 a share topped the near-$3.02 consensus. The stock fell 20.2% that day.

The market wasn't punishing the quarter it just reported; it was reading the quarter coming. Management trimmed full-year revenue to a $3.68 billion midpoint and, more tellingly, guided the September quarter to $924.5 million — growth of about 14%, well below the Street's $942 million. After years of 20%+ growth, that guided deceleration is a genuine and measurable reset, and the drop was the market repricing it.

The moving part is customers, not revenue

Now the number that matters most of all. HubSpot added 7,000 net new customers in the quarter, short of the 9,000–10,000 it had been targeting, and projected just 5,000–6,000 more this quarter.

That's the bear fact, and it deserves to be answered rather than waved off. Management's explanation is that this is a self-inflicted transition, not lost demand. HubSpot is shifting toward AI-focused, outcome-based pricing, which lengthens sales cycles and pushes approvals from department heads up to C-suite and board level; tighter corporate software budgets compound the effect. CEO Yamini Rangan has defended the move as a bet that slower, larger deals are more durable. The bulls would add that this is exactly how a land-grab SMB vendor looks when it pivots upmarket toward bigger, more strategic wins.

But I'd hold the frame open longer than management's script does. The same evidence — slowing customer adds — is also consistent with an AI-native software market that has genuinely changed the cost of acquiring small customers. Both readings fit the data. That uncertainty, not the quarter, is why this trade is a knife rather than a gift.

What ~17x forward earnings is really asking

Here's where the contrarian case earns its scrutiny. The company guided 2026 adjusted EPS to $13.27, which at the current price near $225 puts the stock at roughly 17x forward earnings — essentially in line with the broad market. The re-rating has been brutal: HubSpot now trades near 3.3x sales while Salesforce, growing far more slowly, trades near 4.6x. The faster grower is the cheaper of the two on price-to-sales. On cash, about $658 million in trailing free cash flow against an $11.2 billion market cap is a near-6% free-cash-flow yield.

That is the core of this setup: a high-margin, still-fast-growing software business has been compressed to market-like multiples, and management has put $1 billion behind its own view via a buyback. When a forward multiple converges with the market while growth still runs at multiples of it, the burden of proof shifts to the bears. That's the best single argument the bulls have, and it is a real one.

The moat test matters here too. The fear is that AI eats HubSpot the way AI-natives are said to eat every incumbent. So far the data points the other way: adoption of HubSpot's AI "Data Agent" grew about 80% sequentially and the platform keeps expanding into revenue and billing. The customers-add slowdown is execution and pricing friction, not yet an AI dislodgement. "Competition exists" is not the same as "the moat is breached."

The decider

So which is it — a value trap or a rare mis-pricing? The honest answer is that the evidence doesn't fully decide it yet, and a disciplined reader shouldn't pretend it does. The whole thesis rises or falls on one observable: whether the customer-add rate stabilizes while revenue holds near high teens. If new customer adds keep sliding and growth sinks structurally into the low-to-mid teens, the market's new multiple is roughly right and there's no contrarian edge — the market will have been seeing real damage. If the add-rate stabilizes and the AI/upmarket pivot starts landing bigger deals, then this ~17x forward price on a ~20%-grower is the kind of disconnect the rest of the holding period is built on.

Most of the post-earnings analyst downgrades were price-target cuts rather than thesis reversals, which is consistent with a market marking down a good company's near-term path. That means you get to choose your timing. Don't chase the halved price on hope alone. The buyback and the guidance floor give this a reasonable base, but the reacceleration the stock's recovery depends on has not been proven yet — it has been promised by management. Let the next quarter or two show you whether customers are coming back before you treat ~17x forward earnings as a gift rather than a test.